The American Journal of Managed Care16 天
Eculizumab Shows Promise in Thymoma-Associated Myasthenia Gravis
Eculizumab effectively reduced MG-ADL scores and corticosteroid use in thymoma-associated myasthenia gravis patients by week 12. The monoclonal antibody targets complement protein C5, preventing ...
rarediseaseadvisor28 天
Ravulizumab May Be Beneficial for Patients With Thymoma-Associated MG
Ravulizumab had an early and sustained clinical effect which contributed to the avoidance of intubation. A patient with thymoma-associated myasthenia gravis (MG) was successfully treated with ...
Pharmaceutical Technology1 个月
CBX-12 by Cybrexa for Thymoma (Thymic Epithelial Tumor): Likelihood of Approval
CBX-12 is under clinical development by Cybrexa and currently in Phase II for Thymoma (Thymic Epithelial Tumor). According to GlobalData, Phase II drugs for Thymoma (Thymic Epithelial Tumor) does not ...
American Cancer Society4 年
What Is Thymus Cancer?
Type A: The cells in these tumors are spindle-shaped or oval epithelial cells that are fairly normal looking. This is the rarest type of thymoma, but it seems to have the best outlook. Type AB: This ...